Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.49
+0.01 (0.01%)
At close: Jan 21, 2026, 4:00 PM EST
33.48
-0.01 (-0.01%)
After-hours: Jan 21, 2026, 4:10 PM EST
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.2 billion as of January 21, 2026. Its market cap has increased by 19.83% in one year.
Market Cap
2.20B
Enterprise Value
-1.36B
1-Year Change
19.83%
Ranking
Category
Stock Price
$33.49
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.20B, an increase of 18.22%. That is a compound annual growth rate of 1.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 2.21B | 2.39% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 2.36B |
| Soleno Therapeutics | 2.34B |
| Sarepta Therapeutics | 2.24B |
| Ultragenyx Pharmaceutical | 2.19B |
| Mesoblast | 2.18B |
| Harmony Biosciences Holdings | 2.11B |
| Nuvation Bio | 2.11B |
| Maze Therapeutics | 2.10B |